+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Cell and Gene Therapy Tools and Reagents: Global Markets

  • PDF Icon

    Report

  • 139 Pages
  • October 2022
  • Region: Global
  • BCC Research
  • ID: 5527551

The scope of this study encompasses an investigation of cell and gene therapy tools: GMP proteins, media, cell separation and activation reagents, viral and non-viral, cytokine release syndrome monitoring products, GMP antibodies, leukapheresis instrumentation, immunoassays (multiplex and singleplex) and bioreactors. BCC Research analyzes each tool type, determines its current market status, examines its impact on future markets and presents forecasts of growth over the next six years. The current report provides detailed analysis of the market's drivers, challenges and opportunities. The report also covers market projections to 2027 and market share for key market players. The report includes the company profiles of key players with detailed information about business segments, financials, product portfolios and recent developments. The report provides impact analysis of the COVID-19 pandemic on this market.

Report Includes

  • 105 total tables
  • An updated overview of the global market for immunoassay-based cell and gene therapy tools and reagents
  • Analyses of the global market trends, with historic market revenue for 2019-2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
  • Highlights of the market potential for the cell and gene therapy tools and reagents in the life sciences industry, growth driving factors, and areas of focus to forecast this market into various segments and sub-segments
  • Estimation of actual market size and revenue forecast for cell and gene therapy tools and reagents in USD million terms, and corresponding market share analysis based on product, application/disease area, end-user, and region
  • In-depth information (facts and figures) concerning major market dynamics (DROs), product innovations, clinical trials, and various government regulations affecting the market outlook for cell and gene therapy tools and reagents
  • Review of prevalence of infectious disease, metabolic disorders and chronic ailments; along with the recent technological advancements, competitive environment, and the industry value chain analysis
  • Coverage of the technological, economic, and business considerations of the prevailing cell and gene therapy tools market, and its vendor landscape
  • Patent review and new developments, R&D efforts, industrial changes with emphasis on recent investments, and current state of the immunoassay technology
  • Identification of the companies best positioned to meet the demand for cell and gene therapy in life sciences applications owing to their proprietary technologies, novel product launches, key mergers and acquisition deals, and other strategic advantages
  • Descriptive company profiles of the market leading players, including Abcam, Akron Biotech, Adverum Biotechnologies and Avrobio.
Frequently Asked Questions about the Global Cell and Gene Therapy Market

What is the estimated value of the Global Cell and Gene Therapy Market?

The Global Cell and Gene Therapy Market was estimated to be valued at $8.3 Billion in 2022.

What is the growth rate of the Global Cell and Gene Therapy Market?

The growth rate of the Global Cell and Gene Therapy Market is 10.6%, with an estimated value of $13.7 Billion by 2027.

What is the forecasted size of the Global Cell and Gene Therapy Market?

The Global Cell and Gene Therapy Market is estimated to be worth $13.7 Billion by 2027.

Who are the key companies in the Global Cell and Gene Therapy Market?

Key companies in the Global Cell and Gene Therapy Market include Abcam, Akron Biotech, Adverum Biotechnologies, Athersys Inc., Avrobio, Bio, Rad Laboratories, Bio, Techne and Cellgenix.

Table of Contents

  • Chapter 1 Introduction
    1.1 Study Goals and Objectives
    1.2 Reasons for Doing this Study
    1.3 Scope of Report
    1.4 What's New in this Update?
    1.5 Information Sources
    1.6 Methodology
    1.7 Geographic Breakdown
    1.8 Analyst's Credentials
    1.9 Custom Research
    1.10 Related Research Reports

    Chapter 2 Summary and Highlights

    Chapter 3 Market and Technology Background
    3.1 Overview: Cell and Gene Therapy
    3.1.1 Cell Therapy
    3.1.2 Gene Therapy
    3.2 Types of Cell and Gene Therapy
    3.2.1 Gene Therapy
    3.2.2 Cell Therapy
    3.2.3 Evolution and Expansion of Therapies
    3.2.4 Common Equipment Used

    Chapter 4 Market Dynamics
    4.1 Factors Affecting the Market
    4.2 Market Drivers
    4.2.1 Increasing Investment in Cgt R&D
    4.2.2 Capacity Expansions for Clinical and Commercial Manufacturing
    4.2.3 Increasing Incidence of Chronic Diseases
    4.2.4 Increasing Strategic Collaborations and Acquisitions
    4.2.5 Market Restraints
    4.2.6 Complex Manufacturing and Supply Chain
    4.2.7 Lack of Skilled Workforce
    4.2.8 Market Opportunities
    4.3 Impact of Covid-19

    Chapter 5 Market Breakdown, by Application
    5.1 Cell and Gene Therapy Tools and Reagents Market
    5.2 Cancer
    5.3 Rare Diseases
    5.4 Other Diseases

    Chapter 6 Market Breakdown, by End-user
    6.1 Biotechnology and Pharmaceutical Companies
    6.2 Academic and Research Institutes
    6.3 Clinical Laboratories/Hospitals
    6.4 Gmp Proteins

    Chapter 7 Market Breakdown, by Type
    7.1 Gmp Proteins
    7.1.1 Gmp Proteins by Application
    7.1.2 Gmp Proteins, by End-user
    7.2 Media
    7.2.1 Media by Application
    7.2.2 Media by End-user
    7.3 Cell Separation
    7.3.1 Cell-Separation by Application
    7.3.2 Cell Separation by End-user
    7.4 Cell Expansion
    7.4.1 Cell Expansion by Application
    7.4.2 Cell Expansion by End-user
    7.5 Vectors
    7.5.1 Vectors by Application
    7.5.2 Vectors, by End-user
    7.6 Gmp Small Molecules
    7.6.1Gmp Small Molecules by Application
    7.6.2 Gmp Small Molecules, by End-user
    7.7 Gmp Antibodies
    7.7.1 Gmp Antibodies, by Application
    7.7.2 Gmp Antibodies, by End-user
    7.8 Leukapheresis
    7.8.1 Leukapheresis, by Application
    7.8.2 Leukapheresis by End-user
    7.9 Cryopreservation
    7.9.1 Cryopreservation, by Application
    7.9.2 Cryopreservation by End-user
    7.10 Bioreactors
    7.10.1 Bioreactors, by Application
    7.10.2 Bioreactors, by End-user
    7.11 Immunoassays and Multiplex Immunoassays
    7.11.1 Immunoassays, by Application
    7.11.2 Immunoassays, by End-user
    7.11.3 Multiplex Immunoassays, by Application
    7.11.4 Multiplex Immunoassays, by End-user
    7.12 Cytokine Release Testing
    7.12.1 Cytokine Release Testing, by Application
    7.12.2 Cytokine Release Testing by End-user

    Chapter 8 Market Breakdown by Region
    8.1 North America
    8.2 Europe
    8.3 Asia-Pacific
    8.4 Rest of the World

    Chapter 9 Government Regulations
    9.1 Scope of Regulations on Gene Therapy
    9.1.1 Viral and Non-Viral Vectors
    9.1.2 Media
    9.1.3 Gmp Proteins and Antibodies
    9.1.4 Cell Therapy
    9.1.5 Leukapheresis
    9.1.6 Cell Therapy, Gene Therapy and the Ema

    Chapter 10 Patent Review/New Developments
    10.1 Cell and Gene Therapy R&D
    10.1.1 Academia
    10.2 Technology
    10.2.1 Key Patents

    Chapter 11 Competitive Landscape
    11.1 Mergers and Acquisitions
    11.1.1 Strategic Initiatives
    11.2 Competitive Analysis

    Chapter 12 Company Profiles

    Abcam
  • Akron Biotech
  • Adverum Biotechnologies
  • Athersys Inc.
  • Avrobio
  • Bio-Rad Laboratories
  • Bio-Techne
  • Cellgenix
  • Cytiva Life Sciences
  • Fujifilm Irvine Scientific
  • Luminex Corp.
  • Mesoblast Ltd.
  • Merck Kgaa
  • Miltenyi Biotec
  • Organicell
  • Proteintech Group Inc.
  • Sartorius
  • Sino Biological Inc.
  • Stemcell Technologies
  • Thermo Fisher Scientific

List of Tables
Summary Table A: Global Market for Cell and Gene Therapy Tools and Reagents, Through 2027
Summary Table B: Global Market for Cell and Gene Therapy Tools and Reagents, by Region, Through 2027
Table 1: Global Cancer Statistics, 2020
Table 2: Global Market for Cell and Gene Therapy Tools and Reagents, Through 2027
Table 3: Global Cell and Gene Therapy Tools and Reagents Market, by Application, Through 2027
Table 4: Global Cell and Gene Therapy Tools and Reagents Market for Cancer, by Region, Through 2027
Table 5: Global Cell and Gene Therapy Tools and Reagents for Rare Diseases, by Region, Through 2027
Table 6: Global Cell and Gene Therapy Tools and Reagents for Other Diseases, by Region, Through 2027
Table 7: Global Cell and Gene Therapy Tools and Reagents Market, by End User, Through 2027
Table 8: Global Cell and Gene Therapy Tools and Reagents for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 9: Global Cell and Gene Therapy Tools and Reagents Market for Academic and Research Institutes, by Region, Through 2027
Table 10: Global Cell and Gene Therapy Tools and Reagents Market for Clinical Laboratories, by Region, Through 2027
Table 11: Global Cell and Gene Therapy Tools and Reagents Market, by Type, Through 2027
Table 12: Global Market for GMP Proteins, by Region, Through 2027
Table 13: Global Market for GMP Proteins for Cancer, by Region, Through 2027
Table 14: Global Market for GMP Proteins for Rare Diseases, by Region, Through 2027
Table 15: Global Market for GMP Proteins for Other Diseases, by Region, Through 2027
Table 16: Global Market for GMP Proteins for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 17: Global Market for GMP Proteins for Academic and Research Institutes, by Region, Through 2027
Table 18: Global Market for GMP Proteins for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 19: Global Market for Media, by Region, Through 2027
Table 20: Global Market for Cancer Media, by Region, Through 2027
Table 21: Global Market for Media for Rare Diseases, by Region, Through 2027
Table 22: Global Market for Media for Other Diseases, by Region, Through 2027
Table 23: Global Market for Media for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 24: Global Market for Media for Academic and Research Institutes, by Region, Through 2027
Table 25: Global Market for Clinical Laboratory and Hospital Media, by Region, Through 2027
Table 26: Global Market for Cell Separation, by Region, Through 2027
Table 27: Global Market for Cancer Cell Separation, by Region, Through 2027
Table 28: Global Market for Rare Disease Cell Separation, by Region, Through 2027
Table 29: Global Market for Cell Separation for Other Diseases, by Region, Through 2027
Table 30: Global Market for Cell Separation, Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 31: Global Market for Cell Separation, Academic and Research Institutes, by Region, Through 2027
Table 32: Global Market for Cell Separation, Clinical Laboratories and Hospitals, by Region, Through 2027
Table 33: Global Market for Cell Expansion, by Region, Through 2027
Table 34: Global Market for Cell Expansion for Cancer, by Region, Through 2027
Table 35: Global Market for Cell Expansion for Rare Diseases, by Region, Through 2027
Table 36: Global Market for Cell Expansion for Other Diseases, by Region, Through 2027
Table 37: Global Market for Cell Expansion for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 38: Global Market for Cell Expansion, Academic and Research Institutes, by Region, Through 2027
Table 39: Global Market for Cell Expansion for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 40: Global Market for Vectors, by Region, Through 2027
Table 41: Global Market for Cancer Vectors, by Region, Through 2027
Table 42: Global Market for Rare Disease Vectors, by Region, Through 2027
Table 43: Global Market for Vectors for Other Diseases, by Region, Through 2027
Table 44: Global Market for Vectors for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 45: Global Market for Vectors for Academic and Research Institutes, by Region, Through 2027
Table 46: Global Market for Vectors for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 47: Global Market for GMP Small Molecules, by Region, Through 2027
Table 48: Global Market for GMP Small Molecules for Cancer, by Region, Through 2027
Table 49: Global Market for GMP Small Molecules for Rare Diseases, by Region, Through 2027
Table 50: Global Market for GMP Small Molecules for Other Diseases, by Region, Through 2027
Table 51: Global Market for GMP Small Molecules for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 52: Global Market for GMP Small Molecules for Academic and Research Institutes, by Region, Through 2027
Table 53: Global Market for GMP Small Molecules for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 54: Global Market for GMP Antibodies, by Region, Through 2027
Table 55: Global Market for GMP Antibodies for Cancer, by Region, Through 2027
Table 56: Global Market for GMP Antibodies for Rare Diseases, by Region, Through 2027
Table 57: Global Market for GMP Antibodies for Other Diseases, by Region, Through 2027
Table 58: Global Market for GMP Antibodies for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 59: Global Market for GMP Antibodies for Academic and Research Institutes, by Region, Through 2027
Table 60: Global Market for GMP Antibodies for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 61: Global Market for Leukapheresis, by Region, Through 2027
Table 62: Global Market for Leukapheresis for Cancer, by Region, Through 2027
Table 63: Global Market for Leukapheresis for Rare Diseases, by Region, Through 2027
Table 64: Global Market for Leukapheresis for Other Diseases, by Region, Through 2027
Table 65: Global Market for Leukapheresis for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 66: Global Market for Leukapheresis for Academic and Research Institutes, by Region, Through 2027
Table 67: Global Market for Leukapheresis for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 68: Global Market for Cryopreservation, by Region, Through 2027
Table 69: Global Market for Cryopreservation for Cancer, by Region, Through 2027
Table 70: Global Market for Cryopreservation for Rare Diseases, by Region, Through 2027
Table 71: Global Market for Cryopreservation for Other Diseases, by Region, Through 2027
Table 72: Global Market for Cryopreservation for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 73: Global Market for Cryopreservation for Academic and Research Institutes, by Region, Through 2027
Table 74: Global Market for Cryopreservation for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 75: Global Market for Bioreactors, by Region, Through 2027
Table 76: Global Market for Bioreactors for Cancer, by Region, Through 2027
Table 77: Global Market for Bioreactors for Rare Diseases, by Region, Through 2027
Table 78: Global Market for Bioreactors for Other Diseases, by Region, Through 2027
Table 79: Global Market for Bioreactors for Pharmaceutical & Biotechnology Companies, by Region, Through 2027
Table 80: Global Market for Bioreactors for Academic and Research Institutes, by Region, Through 2027
Table 81: Global Market for Bioreactors for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 82: Global Market for Research-Use-Only Immunoassays, by Region, Through 2027
Table 83: Global Market for Research-Use-Only Multiplex Immunoassays, by Region, Through 2027
Table 84: Global Market for Research-Use-Only Immunoassays for Cancer, by Region, Through 2027
Table 85: Global Market for Research-Use-Only Immunoassays for Rare Diseases, by Region, Through 2027
Table 86: Global Market for Research-Use-Only Immunoassays for Other Diseases, by Region, Through 2027
Table 87: Global Market for Research-Use-Only Immunoassays for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 88: Global Market for Research-Use-Only Immunoassays for Academic and Research Institutes, by Region, Through 2027
Table 89: Global Market for Research-Use-Only Immunoassays for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 90: Global Market for Research-Use-Only Multiplex Immunoassays for Cancer, by Region, Through 2027
Table 91: Global Market for Research-Use-Only Multiplex Immunoassays for Rare Diseases, by Region, Through 2027
Table 92: Global Market for Research-Use-Only Multiplex Immunoassays for Other Diseases, by Region, Through 2027
Table 93: Global Market for Research-Use-Only Multiplex Immunoassays for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 94: Global Market for Research-Use-Only Multiplex Immunoassays for Academic and Research Institutes, by Region, Through 2027
Table 95: Global Market for Research-Use-Only Multiplex Immunoassays for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 96: Global Market for Cytokine Release Testing, by Region, Through 2027
Table 97: Global Market for Cytokine Release Testing for Cancer, by Region, Through 2027
Table 98: Global Market for Cytokine Release Testing for Rare Diseases, by Region, Through 2027
Table 99: Global Market for Cytokine Release Testing for Other Diseases, by Region, Through 2027
Table 100: Global Market for Cytokine Release Testing for Pharmaceutical and Biotechnology Companies, by Region, Through 2027
Table 101: Global Market for Cytokine Release Testing for Academic and Research Institutes, by Region, Through 2027
Table 102: Global Market for Cytokine Release Testing for Clinical Laboratories and Hospitals, by Region, Through 2027
Table 103: Global Cell and Gene Therapy Tools and Reagents Market, by Region, Through 2027
Table 104: Mergers and Acquisitions, 2020-2022
Table 105: Competitive Analysis: Cell and Gene Therapy Tools and Reagents Market, 2021

List of Figures
Summary Figure A: Global Market for Cell and Gene Therapy Tools and Reagents, 2019-2027
Summary Figure B: Global Market for Cell and Gene Therapy Tools and Reagents, by Region, 2019-2027
Figure 1: Global Cell and Gene Therapy Tools and Reagents Market, by Application, 2019-2027
Figure 2: Global Cell and Gene Therapy Tools and Reagents, by Application, 2021
Figure 3: Global Cell and Gene Therapy Tools and Reagents for Cancer, by Region, 2019-2027
Figure 4: Global Cell and Gene Therapy Tools and Reagents for Rare Diseases, by Region, 2019-2027
Figure 5: Global Cell and Gene Therapy Tools and Reagents for Other Diseases, by Region, 2019-2027
Figure 6: Global Cell and Gene Therapy Tools and Reagents, by End User, 2019-2027
Figure 7: Global Cell and Gene Therapy Tools and Reagents, by End User, 2021
Figure 8: Private Investment, Cell and Gene Therapy, 2014-2021
Figure 9: Global Cell and Gene Therapy Tools and Reagents for Pharmaceutical and Biotechnology Companies, by Region, 2019-2027
Figure 10: Global Cell and Gene Therapy Tools and Reagents Market for Academic and Research Institutes, by Region, 2019-2027
Figure 11: Global Cell and Gene Therapy Tools and Reagents Market for Clinical Laboratories, by Region, 2019-2027
Figure 12: Global Cell and Gene Therapy Tools and Reagents Market, by Type, 2019-2027
Figure 13: Global Cell and Gene Therapy Tools and Reagents Market, by Type, 2021
Figure 14: Global Market for GMP Proteins, by Region, 2019-2027
Figure 15: Global Market for Media, by Region, 2019-2027
Figure 16: Global Market for Cell Separation, by Region, 2019-2027
Figure 17: Global Market for Cell Expansion, by Region, 2019-2027
Figure 18: Vectors Used in Gene Therapy Clinical Trials, 2018
Figure 19: Global Market for Vectors, by Region, 2019-2027
Figure 20: Global Market for GMP Small Molecules, by Region, 2019-2027
Figure 21: Global Market for GMP Antibodies, by Region, 2019-2027
Figure 22: Global Market for Leukapheresis, by Region, 2019-2027
Figure 23: Global Market for Cryopreservation, by Region, 2019-2027
Figure 24: Global Market for Bioreactors, by Region, 2019-2027
Figure 25: Global Market for Research-Use-Only Immunoassays, by Region, 2019-2027
Figure 26: Global Market for Research-Use-Only Multiplex Immunoassays, by Region, 2019-2027
Figure 27: Global Market for Cytokine Release Testing, by Region, 2019-2027
Figure 28: Global Cell and Gene Therapy Tools and Reagents Market, by Region, 2019-2027
Figure 29: Global Cell and Gene Therapy Tools and Reagents Market, by Region, 2021
Figure 30: U.S. Market for Cell and Gene Therapy Tools and Reagents, 2019-2027
Figure 31: China Market for Cell and Gene Therapy Tools and Reagents, 2019-2027
Figure 32: Bio-Rad Laboratories Inc.: Annual Revenue, 2019-2021
Figure 33: Bio-Rad Laboratories Inc.: Market Share, by Business Segment, 2021
Figure 34: Bio-Rad Laboratories Inc.: Revenue Share, by Region/Country, 2021
Figure 35: Bio-Techne: Annual Revenue, 2019-2021
Figure 36: Bio-Techne: Market Share, by Business Segment, 2021
Figure 37: Bio-Techne: Revenue Share, by Region/Country, 2021
Figure 38: Danaher Life Science Segment (including Cytiva): Annual Revenue, 2019-2021
Figure 39: Danaher Life Sciences Segment (Including Cytiva): Market Share, by Region, 2021
Figure 40: Merck KGaA Life Sciences Segment: Annual Revenue, 2019-2021
Figure 41: Merck KGaA Life Sciences Segment: Revenue, by Region, 2021
Figure 42: Merck KGaA Life Sciences Segment: Revenue Share, by Segment, 2021
Figure 43: Sartorius: Annual Revenue, 2019-2021
Figure 44: Sartorius: Market Share, by Region, 2021
Figure 45: Sartorius: Market Share, by Business Segment, 2021
Figure 46: Thermo Fisher Scientific Inc.: Annual Revenue, 2019-2021
Figure 47: Thermo Fisher Scientific Inc.: Market Share, by Region, 2021
Figure 48: Thermo Fisher Scientific Inc.: Market Share, by Business Segment, 2021

Executive Summary

Cell and gene therapies (CGT) are a novel therapeutic modality for a range of chronic and age-related conditions. These provide a fundamental treatment option for disease conditions that do not have a cure or cannot be treated with conventional drugs. Initially, cell and gene therapies were highly explored for oncology. However, the research is expanding into other areas including autoimmune diseases, rare diseases, musculoskeletal diseases, cardiovascular diseases and dermatological diseases. Cell and gene therapy have potential applications in many disease areas, including cancers, autoimmune diseases, urinary disorders, spinal cord injuries, type I diabetes, Parkinson's disease, Alzheimer's disease, heart disease, stroke, burns and osteoarthritis.

Demand for cell and gene therapies is high and there is a lot of R&D in this segment supported by huge investments and funding for CGTs. The number of clinical trials and regulatory approvals for cell and gene therapies will increase over the coming years.

Increasing investments, capacity expansions for clinical and commercial manufacturing, increasing prevalence of chronic diseases and increased healthcare expenditure drive the cell and gene therapy tools and reagents market. There have been accelerated approvals in recent years coupled with technological advancements (development of off-the-shelf products and application of advanced gene editing techniques like CRISPR) will lower the complexities involved around manufacturing CGTs and will attract many pharma and biotech companies to enter the market.

The cell and gene therapy tools and reagents market is segmented based on application, type, end user and region. Major players in the market are Thermo Fisher, Merck KGaA, Cytiva, Miltenyi Biotech, Sartorius and Bio-Rad Laboratories.

The North American region has the highest share, followed by Europe. Extensive R&D activities take place in the region, there are major players present, plentiful funding and an increasing prevalence of chronic diseases. All these factors contribute to growth in the market. Based on application, the cancer segment has the highest share.

Companies Mentioned

  • Abcam
  • Akron Biotech
  • Adverum Biotechnologies
  • Athersys Inc.
  • Avrobio
  • Bio-Rad Laboratories
  • Bio-Techne
  • Cellgenix
  • Cytiva Life Sciences
  • Fujifilm Irvine Scientific
  • Luminex Corp.
  • Mesoblast Ltd.
  • Merck Kgaa
  • Miltenyi Biotec
  • Organicell
  • Proteintech Group Inc.
  • Sartorius
  • Sino Biological Inc.
  • Stemcell Technologies
  • Thermo Fisher Scientific